The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,960.00
Bid: 1,969.00
Ask: 1,971.00
Change: 35.00 (1.82%)
Spread: 2.00 (0.102%)
Open: 1,937.00
High: 1,977.00
Low: 1,931.00
Prev. Close: 1,925.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET MIDDAY: Travel Stocks Bear Brunt As Virus Fears Heighten

Thu, 27th Feb 2020 11:54

(Alliance News) - London stocks continued to post steep losses at midday on Thursday with travel firms once again among the hardest hit as the coronavirus outbreak expanded into Europe.

The FTSE 100 was down 144.18 points, or 2.1%, at 6,898.29 on Thursday. The mid-cap FTSE 250 index was down 530.98 points, or 2.6%, at 20,091.97 at midday and the AIM All-Share index was down 2.2% at 891.36.

The Cboe UK 100 index was down 2.0% at 11,683.22. The Cboe 250 was down 2.7% at 18,056.09, while the Cboe Small Companies was down 0.8% at 11,970.94.

In mainland Europe, both the CAC 40 in Paris and the DAX 30 in Frankfurt were 2.3% lower.

"The number of confirmed cases of coronavirus is on the rise, and so is the number of countries that have infections. Dealers are dreading a pandemic as they are afraid economic activity will be reduced as lockdowns will disrupt the business world," said David Madden at CMC Markets.

Authorities in Italy have reported that the number of people infected in the country grew to 447 and 12 people have died, while Denmark reported its first case.

Romania, Greece and neighbouring North Macedonia registered their first confirmed virus cases on Wednesday, involving people who recently travelled to Italy's afflicted north. The first cases reported in Austria, Croatia and Switzerland on Tuesday also had travel ties to northern Italy.

South Korea reported 505 more cases on Thursday, bringing its total to 1,766. China reported 433 new cases along with 29 additional deaths, with 383 of the new cases in the epicentre of the city of Wuhan, where the virus first emerged in December.

Since the new coronavirus emerged in December in central China, there have been at least 82,000 cases globally, with more than 2,700 deaths.

"The tourism sector has suffered greatly this week for fear that people's travel plans will be shelved. TUI, easyJet and BA's parent, International Consolidated Airlines Group shares are all nursing heavy losses," said CMC's Madden.

TUI shares were down 6.5%, easyJet down 10% and IAG down 8.4%. The FTSE 350 travel & leisure sector is one of the worst performers so far this week, down 12%.

Stocks in the US are also on course for a downbeat session on Thursday, with the Dow pointed 1.0% lower, the S&P 500 also down 1.0% and the Nasdaq off 0.9%.

Safe havens remained firm in the risk-off environment. Gold was quoted at USD1,648.10 an ounce on Thursday, up from USD1,637.00 on Wednesday.

The Japanese yen, another safe haven, also was higher. Against the yen, the dollar was quoted at JPY110.06, down from JPY110.52.

Oil, meanwhile, was trading around its lowest levels since late 2018. Brent oil was trading at USD52.29 a barrel on Thursday, lower than USD54.45 late Wednesday in London.

Sterling was quoted at USD1.2872 on Thursday, flat on USD1.2920 at the London equities close on Wednesday. The euro traded at USD1.0939 on Thursday, higher than USD1.0866 late Wednesday.

The European Commission showed economic sentiment increased in the euro area in February.

The economic sentiment indicator increased by 0.9 points to 103.5 in February, largely due to higher confidence among consumers.

Consumer confidence was up 1.5 points to minus 6.6 from minus 8.1 in January.

The mood among consumers lifted "thanks to households' much brighter expectations in respect of the general economic situation, which outstripped slightly more upbeat appraisals of their past and future financial situation, as well as their intentions to make major purchases."

ING, though, didn't get carried away with the figures given the coronavirus outbreak.

"Before getting too excited about the positive figures, we must remember the survey is conducted within the first two to three weeks of the month. The number of Covid-19 cases outside of China only started to increase significantly after 21 February. In other words, the survey was done at a time when Europe considered Covid-19 largely a Chinese problem with some minor negative effects on the rest of the world," highlighted ING.

Back in London, WPP was the worst performer in the FTSE 100, sinking 15%.

WPP's 2019 revenue from continuing operations was up 1.4% to GBP13.23 billion from GBP13.05 billion, but pretax profit slumped 22% to GBP982 million from GBP1.26 billion. Billings, meanwhile, slipped 0.3% to GBP53.06 billion GBP53.22 billion. Like-for-like billings were down 1.0% in 2019.

Revenue less pass-through costs came in 0.3% lower at GBP10.85 billion, from GBP10.88 billion. For 2020, the company expects revenue less pass-through costs to be flat year-on-year, although WPP said this guidance was made prior to any impact from the coronavirus outbreak.

The top blue-chip performer was Hikma, up 4.3% as it reported profit growth for 2019.

The FTSE 100-listed pharmaceuticals firm said group revenue in 2019 rose 7% to USD2.2 billion from USD2.07 billion in 2018, reflecting good growth in each of the three business.

Pretax profit grew to USD493 million from USD293 million in 2018, also reflecting strong performance of its three business segments.

In the FTSE 250, Aston Martin slumped 12% as it confirmed details of its GBP500 million funding plan after enduring a torrid 2019 that brought wider losses.

Aston Martin also announced the departure of Chief Financial Officer Mark Wilson "by no later than" the end of April. A process has begun to find a successor. It said the change was "following discussions and by mutual agreement".

The luxury carmaker's revenue in 2019 fell 9% on the year before to GBP997.3 million, with wholesale volumes also down 9%, to 5,862 units. Gaydon, Warwickshire-based Aston Martin posted a pretax loss of GBP104.3 million for the year, widening from GBP68.2 million.

Playtech shares slipped 12% as it warned results for 2020 will be below market expectations.

Revenue for 2019 rose 23% to EUR1.51 billion, up 22% at constant currency. Adjusted earnings before interest, tax, depreciation and amortisation was up 11% to EUR383.1 million, but pretax profit slumped to EUR48.2 million from EUR187.7 million.

For 2020 as a whole, Playtech warned results are likely to be below market expectations, having seen a "material impact" in the last two weeks from changes in normal customer patterns due to Covid-19. The virus is "significantly affecting" two of the company's largest markets, it added.

To come in the economic calendar on Thursday is a fourth quarter US gross domestic product reading at 1330 GMT.

By Lucy Heming; lucyheming@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
3 Jan 2023 09:25

Hikma launches version of Xyrem medicine in US for treating narcolepsy

(Alliance News) - Hikma Pharmaceuticals PLC on Tuesday said it launched an authorised generic version of the Xyrem sodium oxybate prescription medicine in the US for treating narcolepsy.

Read more
3 Jan 2023 09:24

LONDON BROKER RATINGS: Citigroup cuts Wizz Air; Redburn likes CRH

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning, Monday and late Friday:

Read more
3 Jan 2023 09:03

LONDON MARKET OPEN: Stocks jump in first session of 2023

(Alliance News) - Stock prices in London made a strong start to the new year on Tuesday, despite weak Chinese data and the UK suffering a fresh wave of rail strikes.

Read more
3 Jan 2023 07:58

LONDON BRIEFING: Stocks called higher; China factory sector shrinks

(Alliance News) - Stocks in London are expected to start a new year on the front foot on Tuesday, after a mixed session in Asia amid weak Chinese economic data.

Read more
3 Jan 2023 07:46

Hikma launches generic narcolepsy solution in US

(Sharecast News) - Hikma Pharmaceuticals has launched an authorised generic version of Jazz Pharmaceuticals' 'Xyrem 1', or sodium oxybate oral solution, it announced on Tuesday.

Read more
8 Dec 2022 09:48

LONDON BROKER RATINGS: JPMorgan cuts Travis Perkins; BofA likes IAG

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
6 Dec 2022 10:48

RBC Capital Markets starts Hikma at 'outperform'

(Sharecast News) - RBC Capital Markets initiated coverage of Hikma Pharmaceuticals on Tuesday at 'outperform' with a 1,750p price target.

Read more
6 Dec 2022 10:26

LONDON BROKER RATINGS: JPMorgan cuts Lloyds but raises Barclays

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
15 Nov 2022 12:10

Credit Suisse initiates coverage of Hikma at 'outperform'

(Sharecast News) - Credit Suisse has initiated coverage of Hikma Pharmaceuticals with an 'outperform' rating.

Read more
15 Nov 2022 09:58

LONDON BROKER RATINGS: Jefferies cuts Aston Martin to 'underperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
14 Nov 2022 09:25

LONDON BROKER RATINGS: Credit Suisse cuts Ferrexpo to 'neutral'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
8 Nov 2022 09:39

LONDON BROKER RATINGS: Peel cuts Persimmon; Liberum raises Hammerson

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
3 Nov 2022 11:17

Hikma Pharmaceuticals reiterates 2022 guidance as costs widen

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reiterated annual guidance for all three of its businesses, continuing to expect them to underperform against 2021 due to rising costs.

Read more
3 Nov 2022 11:08

With tighter purse strings, is parity less probable for the pound?

STOXX 600 down 1.1%

*

Read more
3 Nov 2022 09:28

Banks, insurance dodge carnage as real estate stocks sink

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at .

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.